Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Non-Current Assets: 2010-2024

Historic Non-Current Assets for Altimmune (ALT) over the last 15 years, with Dec 2024 value amounting to $2.1 million.

  • Altimmune's Non-Current Assets fell 12.97% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 12.97%. This contributed to the annual value of $2.1 million for FY2024, which is 102.37% up from last year.
  • Per Altimmune's latest filing, its Non-Current Assets stood at $2.1 million for FY2024, which was up 102.37% from $1.0 million recorded in FY2023.
  • Altimmune's Non-Current Assets' 5-year high stood at $14.9 million during FY2020, with a 5-year trough of $1.0 million in FY2023.
  • In the last 3 years, Altimmune's Non-Current Assets had a median value of $2.1 million in 2024 and averaged $5.7 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first slumped by 92.82% in 2023, then soared by 102.37% in 2024.
  • Over the past 5 years, Altimmune's Non-Current Assets (Yearly) stood at $14.9 million in 2020, then declined by 0.80% to $14.7 million in 2021, then decreased by 4.23% to $14.1 million in 2022, then crashed by 92.82% to $1.0 million in 2023, then skyrocketed by 102.37% to $2.1 million in 2024.